PortfoliosLab logoPortfoliosLab logo
RIGL vs. IDCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RIGL vs. IDCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rigel Pharmaceuticals, Inc. (RIGL) and InterDigital, Inc. (IDCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RIGL achieves a -23.30% return, which is significantly lower than IDCC's -10.49% return. Over the past 10 years, RIGL has underperformed IDCC with an annualized return of 3.28%, while IDCC has yielded a comparatively higher 19.26% annualized return.


RIGL

1D
2.40%
1M
2.24%
YTD
-23.30%
6M
-19.45%
1Y
54.23%
3Y*
27.10%
5Y*
-3.96%
10Y*
3.28%

IDCC

1D
2.56%
1M
5.00%
YTD
-10.49%
6M
-19.56%
1Y
29.08%
3Y*
48.27%
5Y*
30.63%
10Y*
19.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RIGL vs. IDCC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RIGL
Rigel Pharmaceuticals, Inc.
-23.30%154.64%16.00%-3.33%-43.40%-24.29%63.55%-6.96%-40.72%63.03%
IDCC
InterDigital, Inc.
-10.49%66.05%81.06%123.67%-29.25%20.49%14.28%-16.11%-11.23%-15.34%

Correlation

The correlation between RIGL and IDCC is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 29, 2000

0.26

The correlation between RIGL and IDCC shifts across timeframes, from 0.11 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

RIGL:

$646.69M

IDCC:

$10.01B

EPS

RIGL:

$19.21

IDCC:

$10.51

PE Ratio

RIGL:

1.71

IDCC:

27.00

PEG Ratio

RIGL:

0.00

IDCC:

0.34

PS Ratio

RIGL:

2.08

IDCC:

11.93

PB Ratio

RIGL:

1.62

IDCC:

9.07

Total Revenue (TTM)

RIGL:

$299.77M

IDCC:

$828.92M

Gross Profit (TTM)

RIGL:

$279.95M

IDCC:

$537.64M

EBITDA (TTM)

RIGL:

$125.80M

IDCC:

$508.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RIGL vs. IDCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RIGL
RIGL Risk / Return Rank: 6767
Overall Rank
RIGL Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
RIGL Sortino Ratio Rank: 7070
Sortino Ratio Rank
RIGL Omega Ratio Rank: 6969
Omega Ratio Rank
RIGL Calmar Ratio Rank: 6565
Calmar Ratio Rank
RIGL Martin Ratio Rank: 6161
Martin Ratio Rank

IDCC
IDCC Risk / Return Rank: 6161
Overall Rank
IDCC Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
IDCC Sortino Ratio Rank: 6060
Sortino Ratio Rank
IDCC Omega Ratio Rank: 6262
Omega Ratio Rank
IDCC Calmar Ratio Rank: 6060
Calmar Ratio Rank
IDCC Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RIGL vs. IDCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and InterDigital, Inc. (IDCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RIGLIDCCDifference
Sharpe ratioReturn per unit of total volatility

+0.16

Sortino ratioReturn per unit of downside risk

+0.49

Omega ratioGain probability vs. loss probability

1.20

1.16

+0.05

Calmar ratioReturn relative to maximum drawdown

1.09

0.80

+0.29

Martin ratioReturn relative to average drawdown

1.91

1.92

-0.02

RIGL vs. IDCC - Sharpe Ratio Comparison

The current RIGL Sharpe Ratio is 0.78, which is comparable to the IDCC Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of RIGL and IDCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RIGL vs. IDCC - Drawdown Comparison

The maximum RIGL drawdown since its inception was -99.37%, which is greater than IDCC's maximum drawdown of -93.83%. Use the drawdown chart below to compare losses from any high point for RIGL and IDCC.


Loading charts...

Drawdown Indicators


RIGLIDCCDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-93.83%

-5.54%

Max Drawdown (1Y)

Largest decline over 1 year

-50.08%

-36.48%

-13.60%

Max Drawdown (3Y)

Largest decline over 3 years

-57.75%

-36.48%

-21.27%

Max Drawdown (5Y)

Largest decline over 5 years

-85.24%

-48.72%

-36.52%

Max Drawdown (10Y)

Largest decline over 10 years

-86.40%

-64.94%

-21.46%

Current Drawdown

Current decline from peak

-96.93%

-28.13%

-68.80%

Average Drawdown

Average peak-to-trough decline

-90.91%

-45.27%

-45.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.64%

15.16%

+13.48%

Volatility

RIGL vs. IDCC - Volatility Comparison

Rigel Pharmaceuticals, Inc. (RIGL) and InterDigital, Inc. (IDCC) have volatilities of 12.05% and 11.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RIGLIDCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.05%

11.82%

+0.23%

Volatility (6M)

Calculated over the trailing 6-month period

36.64%

36.83%

-0.19%

Volatility (1Y)

Calculated over the trailing 1-year period

69.89%

47.07%

+22.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.46%

35.74%

+49.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.81%

35.59%

+47.22%

Dividends

RIGL vs. IDCC - Dividend Comparison

RIGL has not paid dividends to shareholders, while IDCC's dividend yield for the trailing twelve months is around 0.95%.


PositionTTM20252024202320222021202020192018201720162015
IDCC
InterDigital, Inc.
0.95%0.74%0.85%1.34%2.83%1.95%2.31%2.57%2.11%1.64%0.99%1.63%
RIGL
Rigel Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

RIGL vs. IDCC - Financials Comparison

This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and InterDigital, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M20222023202420252026
58.82M
205.42M
(RIGL) Total Revenue
(IDCC) Total Revenue
Values in USD except per share items

RIGL vs. IDCC - Profitability Comparison

The chart below illustrates the profitability comparison between Rigel Pharmaceuticals, Inc. and InterDigital, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
92.2%
0
Portfolio components
RIGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.

IDCC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, InterDigital, Inc. reported a gross profit of 0.00 and revenue of 205.42M. Therefore, the gross margin over that period was 0.0%.

RIGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.

IDCC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, InterDigital, Inc. reported an operating income of 82.26M and revenue of 205.42M, resulting in an operating margin of 40.1%.

RIGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.

IDCC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, InterDigital, Inc. reported a net income of 75.33M and revenue of 205.42M, resulting in a net margin of 36.7%.


Frequently Asked Questions


RIGL and IDCC have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RIGL has higher volatility (12.05%) compared to IDCC (11.82%). In terms of maximum drawdown, RIGL dropped -99.37% vs IDCC's -93.83%.

RIGL currently has the higher Sharpe Ratio (0.78 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RIGL and IDCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer